Genetic Intelligence
Genetic Intelligence identifies genetically defined disease targets and accelerates development of RNA-targeted therapeutics. The company uses an AI-driven computational platform that analyzes RNA sequence and structure to nominate targets and design modalities such as oligonucleotides and small molecules. Its approach integrates machine learning with genomic and transcriptomic datasets to predict mechanisms and prioritize drug candidates. Genetic Intelligence operates as a B2B drug-discovery partner for pharmaceutical and biotech companies advancing precision RNA medicines. The platform focuses on genetically supported indications to increase likelihood of clinical success.
Genetic Intelligence
Genetic Intelligence identifies genetically defined disease targets and accelerates development of RNA-targeted therapeutics. The company uses an AI-driven computational platform that analyzes RNA sequence and structure to nominate targets and design modalities such as oligonucleotides and small molecules. Its approach integrates machine learning with genomic and transcriptomic datasets to predict mechanisms and prioritize drug candidates. Genetic Intelligence operates as a B2B drug-discovery partner for pharmaceutical and biotech companies advancing precision RNA medicines. The platform focuses on genetically supported indications to increase likelihood of clinical success.